Literature DB >> 35905098

Determinants of personal vaccination hesitancy before and after the mid-2021 COVID-19 outbreak in Taiwan.

Hsuan-Wei Lee1, Cheng-Han Leng2, Ta-Chien Chan3.   

Abstract

BACKGROUND: Using a 10 week nationwide online survey performed during a time period containing the time ahead, the start, and the peak of a COVID-19 outbreak in Taiwan, we investigated aspects that could affect participants' vaccination intentions.
METHODS: From March to May 2021, we surveyed 1,773 people in Taiwan, aged from 20 to 75 years, to determine potential acceptance rates and factors influencing the acceptance of a COVID-19 vaccine. We used an ordinal logistic regression with a backward selection method to identify factors that affected vaccination intention.
RESULTS: Several factors could increase individuals' vaccination intentions including: being male, older, with an openness personality, having a better quality of life in the physical health domain, having better knowledge and personal health behavior, having more trust in the government, and being worried about misinformation. Perceived risks played a crucial role in the vaccine decision-making process. When the pandemic intensified, people's vaccination intentions increased significantly.
CONCLUSION: The findings of the present study could highlight individuals' vaccination attitudes and provide governments with an empirical and dynamic base to design tailored strategies to increase vaccination rates.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35905098      PMCID: PMC9337646          DOI: 10.1371/journal.pone.0270349

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.752


Introduction

As SARS-CoV-2 infections have surged around the world [1], countries have been eager to reach higher vaccination rates among their citizens to achieve herd immunity and prevent the further spread of the pandemic. Some governments made COVID-19 vaccinations mandatory for health practitioners and other high-risk groups [2], while other countries like the United States and France debated the vaccine mandate. Therefore, understanding the factors that affect people’s vaccination intentions is crucial for governments to effectively increase the vaccination rate in their countries. Multiple studies have been conducted on vaccine intention in different countries such as Australia [3, 4], Canada [5], China [6], Czechia [7, 8], France [9], Germany [10], Greece [11], Hong Kong [12, 13], India [14], Indonesia [15], Japan [16, 17], Malaysia [18], New Zealand [19], Portugal [20], Saudi Arabia [21, 22], Slovenia [23], the United Kingdom [24-27], the Caribbean region [28], the United States [29-33], and Taiwan [34, 35]. There are also cross-country surveys [36-43]. Most of these studies offered public health perspectives and investigated major demographic factors that influenced people’s vaccination intention during certain snapshots of time. Among various vaccine intention studies, one study conducted a multinational survey in June 2020 involving 13,426 people from 19 countries, among them, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine [42]. Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and to take their employer’s advice to do so. A recent study performed a systematic literature search of PubMed and Web of Science before July 2021, and showed a variety of factors that could lead to vaccine hesitancy, including having a negative perception of vaccine efficacy, safety, convenience, and price [44]. Compared to other countries, Taiwan had remarkable success in containing the COVID-19 epidemic [45-48], recording zero local spread cases from April to December 2020. While many countries around the world suffered from the COVID-19 pandemic in 2020, due to no local epidemic, the vaccine acceptance rate in Taiwan is much lower than in neighboring countries at the beginning of vaccination campaign [43]. As of April 2021, a study had performed an online survey over 18 days to collect a sample of 1,100 responses in Taiwan [35]. The authors found that certain demographic characteristics including being male and psychological factors such as the belief in the artificial origin of the virus could suppress people’s COVID-19 vaccination intention in Taiwan. Though insightful, one limitation of this study was its timeliness. This study was conducted in early April 2021, when Taiwan’s daily number of infected cases was extremely low (0.14 daily new confirmed COVID-19 cases per million people [49]). However, in May 2021, the COVID-free normality enjoyed by Taiwanese for almost a year ended. The government issued a Level 3 pandemic alert on May 15, 2021 (1.75 daily new confirmed COVID-19 cases per million people [49]), to limit the spread of the virus. The outbreak soon reached its peak in late May. During the 2021 outbreak, the Taipei metropolitan area became an epicenter for infections. During the outbreak, the vast majority was unvaccinated then, only less than 1% of the population was vaccinated [50]. Noticeably, there were insufficient vaccines for most residents in Taiwan causing the population to feel stressed and anxious [51]. We assumed that although the different variants of SARS-CoV-2 virus were rampant around the world, the lack of infections in Taiwan meant that people’s vaccine intentions remained low. By contrast, once threats were imminent, such as due to a local outbreak, people’s perceived risk and willingness to be vaccinated would increase dramatically. This study aimed to explore people’s motivations to be vaccinated in association with factors such as their demographic characteristics, psychological perspectives, health-related behavior, political attitudes, and most importantly, the COVID-related risk factors including people’s locations, quarantine experiences, and the number of daily new confirmed cases in Taiwan. Considering all these factors, we aimed to carry out holistic investigation of why people either do or do not want to be vaccinated. Therefore, the present study has the following three key research questions (RQs): RQ1: What proportion of people would accept a vaccine for COVID-19? RQ2: What sociodemographic factors, psychological factors, and health and political attitudes are associated with the intention to accept a future vaccine for COVID-19? RQ3: How do COVID-related risk factors and potential threats affect one’s vaccine intention?

Materials and methods

To investigate which factors affect people’s willingness to get vaccinated, we performed a 10-week online nationwide survey in Taiwan. Fig 1 illustrates Taiwan’s mid-2021 COVID-19 outbreak and our survey period [49]. Our survey period covered the early development and the peak of the mid-2021 outbreak. During this period, the population of Taiwan experienced a substantial change in their attitude toward COVID-19.
Fig 1

The timeline and casualties of Taiwan’s mid-2021 COVID-19 outbreak and our survey period.

Design

We conducted a cross-sectional survey, from March 20 to May 28, 2021. Participants were recruited via multiple social media platforms and were directed to our website–Social Distancing Survey–where they could complete the survey with ethical approval (reference: AS-IRB-HS07-109104). Participants entered our website after confirming the electronic informed consent form, which was printed on the front page.

Questionnaire

Our survey consisted of five main parts: the participants needed to provide their (i) basic demographic characteristics, (ii) psychological perspectives, (iii) public health knowledge and personal health behavior, and (iv) attitude towards the government among different aspects, and (v) any COVID-related risk factors. In the psychological part of the survey, participants’ quality of life (QoL) was measured by the WHOQOL-BREF [52]. The WHOQOL-BREF contains four domains: physical health (seven items), psychological health (six items), social relationships (three items), and environment (eight items). Each item followed a five-point Likert scale ranging from low to high QoL. Moreover, the personality traits consist of five factors, namely, openness to experience, conscientiousness, extraversion, agreeableness, and neuroticism [53]. These traits were measured by the Big-Five Inventory [54], and each trait was measured by two items. The scale that was used followed the five-point Likert scale. To understand if the participants had enough public health knowledge and had been practicing good health habits since the global outbreak of COVID-19, we asked how frequently they came into physical contact with other people and entered crowded places. Moreover, we asked if the participants’ would tell their doctors about their sickness and keep social distance if they feel ill, to measure their public health knowledge and attitudes. We also measured a wide range of the participants’ political attitudes toward the Taiwan government. We asked if the participants were satisfied with the government’s performance when dealing with the COVID-19 outbreak; determining if the participant agreed that (a) the government should restrict individual freedom in order to control the COVID-19 outbreak, (b) the government should track how people move around in order to control the outbreak, (c) the government should release personal information of COVID-19 patients for the sake of enhancing people’s understanding of the epidemic situation, (d) the government should provide financial aid due to the economic crisis caused by the outbreak. We also asked the participants (e) how trustworthy they found the information provided by their government about the development of the epidemic, and (f) how worried they were about the negative impact of misinformation related to epidemic prevention on society. Lastly, we investigated the risk factors the participants had in relation to the COVID-19 pandemic. Four additional factors were explored in this category: (a) if the participants were living in Taipei or not, (b) if they had quarantine experience related to COVID-19, (c) whether the participants have had a COVID-19 test, (d) whether the time the participants took the survey was during the national COVID-19 level three alert, and (e) the previous daily new confirmed cases.

Outcome measure

To measure vaccination intention, participants were asked to respond to the item “when a COVID-19 vaccination becomes available to [them]” with the Likert type choices: “1: I won’t take it”, “2: Maybe, maybe not”, and “3: I will take it”. Meanwhile, participants were also asked to provide the reasons for their answers (via multiple choice) “that will affect their incentive to take the COVID-19 vaccine” with the choices of “the physical impact of the vaccine”, “the mental impact of the vaccine”, “the efficacy of the vaccine”, “the price of the vaccine”, “the vaccination process”, and “other reason”, each reason was recorded as a dummy variable.

Analysis

The present study conducted all analyses using R software in version 4.1.1 and used an ordinal logistic regression to build the model with the package “ordinal” [55]. The dependent variable was the strength of the motivation for a vaccination, and the independent variables were the five categories of variables mentioned in the Questionnaire subsection, in addition to the reasons influencing their motivation, as demonstrated in Table 1. Due to the number of variables included, we used a backward selection approach to select the variables with a significance level of.05.
Table 1

All candidate variables in the full model.

a-1gender–male (with the reference of female)
a-2aged over 30 years old (with the reference of aged below 30 years old)
a-3marital status–single (with the reference of married)
a-4education
a-5living place–Taipei (with the reference of outside Taipei)
a-6household income
b-1during the level three alert (with the reference of before the level three alert)
b-2test result–negative (with the reference of untested)
b-3quarantine condition–never-quarantined (with a reference of ever-quarantined)
b-4yesterday’s new confirmed cases
c-1openness to experience
c-2conscientiousness
c-3extraversion
c-4agreeableness
c-5neuroticism
d-1physical health
d-2psychological health
d-3social relationships
d-4environment
edaily contact on average
fthe sufficiency of requisite
g-1personal health behavior when making physical contact with others
g-2personal health behavior when in a crowded place
g-3personal health behavior of telling their doctor when feeling ill
g-4the necessity to wear a mask
h-1the satisfaction with the government
h-2the satisfaction with the World Health Organization (WHO)
h-3the agreement with the government to restrict personal movement
h-4the agreement with the government to track personal movement
h-5the agreement with the government to release patients’ information
h-6the agreement with the financial aids provided by the government
h-7the trustworthiness of government information
h-8the worry of the negative impact of any misinformation
itime spent on the internet
j-1considering the physical impact of the vaccination–yes (with a reference of no)
j-2considering the psychological impact of the vaccination–yes (with a reference of no)
j-3considering the vaccination price–yes (with a reference of no)
j-4considering the vaccination process–yes (with a reference of no)
j-5considering the other reasons for vaccination–yes (with a reference of no)

Results

As demonstrated in Table 2, about half of our participants lived in Taipei (57.53%), two thirds of which were female (67.75%) and aged less than thirty years old (38.04%). Most of the participants were single (83.14%), had higher education (97.94%), and had household income between 1,700 and 3,399 or between 3,400 and 6,799 USD a month. The majority of the participants submitted their responses during the level three alert (76.67%), have not tested for the COVID-19 virus (93.43%), and did not have quarantine experience (89.61%).
Table 2

Demographic characteristics of the participants.

CharacteristicTotal No. (%)Residence No. (%)Population No. (%)
Not TaipeiTaipeiNot TaipeiTaipei
Overall1,773 (100)753 (42.47)1,020 (57.53)16,593,952 (70.77)6,967,274 (29.23)
Gender
 Male555 (31.30)226 (30.01)329 (32.25)11,616,647 (49.61)
 Female1,218 (68.70)527 (69.99)691 (67.75)11,835,190 (50.39)
Age
 < 30 years old1,086 (61.25)454 (60.29)632 (61.96)7,210,318 (30.80)
 ≥ 30 years old687 (38.74)299 (39.71)388 (38.04)16,350,918 (69.20)
Marital status
 Married336 (18.95)164 (21.78)172 (16.86)-
 Single1,437 (81.06)589 (78.22)848 (83.14)-
Education
 Education66 (3.72)45 (5.98)21 (2.06)-
 Higher Education1,707 (96.28)708 (94.02)999 (97.94)-
Household income
 ≤ 329 USD/month60 (3.38)32 (4.25)28 (2.75)-
 330-989 USD/month133 (7.50)68 (9.03)65 (6.37)-
 990-1,699 USD/month318 (17.94)132 (17.53)186 (18.24)-
 1,700-3,399 USD/month611 (34.46)278 (36.92)333 (32.65)-
 3,400-6,799 USD/month531 (29.95)203 (26.96)328 (32.16)-
 ≥ 6,800 USD/month120 (6.77)40 (5.31)80 (7.84)-
Level three alert
 Before363 (20.47)125 (16.60)238 (23.33)-
 During1,410 (79.53)628 (83.40)782 (76.67)-
COVID-19 test result
 Not tested1,668 (94.08)715 (94.95)953 (93.43)-
 Negative105 (5.92)38 (5.05)67 (6.57)-
Quarantine experience
 Ever-quarantined168 (9.48)62 (8.23)106 (10.39)-
 Never-quarantined1,605 (90.52)691 (91.77)914 (89.61)-

USD: United States Dollar

USD: United States Dollar

RQ1: What proportion of people would accept a vaccine for COVID-19?

As demonstrated in Table 3, about half of our participants were willing to vaccinate (52.99−54.51%), which did not differ according to their living place. Also, roughly 40% of the participants might take the vaccination (41.04−40.78%). Most of the participants cared about the risk of the physical impact of the vaccine (80.21−79.99%) and the efficacy of the vaccination (70.65−41.47%). Although it was free to vaccinate in Taiwan, about 40% of the participants remained focused on the price of the vaccine (34.79−41.47%), which might relate to the notion of being vaccinated abroad. About one-third of the participants were worried about the risk of any psychological impact of the vaccine (21.27−21.78%) and the risk of the vaccination process (18.99−20.20%). Few of the participants were worried about other reasons (6.47−8.10%).
Table 3

Motivation for vaccination.

CharacteristicTotal No. (%)Residence No. (%)
Not TaipeiTaipei
Overall1,773 (100)753 (42.47)1,020 (57.53)
Motivation for vaccination
 Will not take it93 (5.25)45 (5.98)48 (4.71)
 Maybe, maybe not725 (40.89)309 (41.04)416 (40.78)
 Will take it955 (53.86)399 (52.99)556 (54.51)
Reasons influencing the motivation
 Physical impact (yes)1,419 (80.03)604 (80.21)815 (79.9)
 Psychological impact (yes)381 (21.49)164 (21.78)217 (21.27)
 Efficacy (yes)1,271 (71.69)532 (70.65)739 (72.45)
 Price (yes)685 (38.64)262 (34.79)423 (41.47)
 Vaccination process (yes)349 (19.68)143 (18.99)206 (20.20)
 Other (yes)127 (7.16)61 (8.10)66 (6.47)

RQ2: What sociodemographic factors, psychological factors, and health and political attitudes are associated with the intention to accept a future vaccine for COVID-19

As shown in Table 4, among the demographic factors, the willingness of men to vaccinate was 1.48 times that of women, and that there was 1.49 times as many participants over the age of 30 as opposed to below the age of 30.
Table 4

Associated factors of the motivation for vaccination.

VariableEstimateOdds Ratio95% C.I.Significance
Demographic factors
 Male0.391.48(1.19, 1.84) ***
 Aged over 30 years old0.41.49(1.21, 1.84) ***
Psychological perspectives
 Openness to experience0.071.07(1.02, 1.14) *
 Physical health0.081.08(1.03, 1.14) ***
 Social Relationships-0.060.94(0.90, 0.98) **
Public health knowledge and personal health behavior
 Go to crowded places0.251.28(1.08, 1.51) **
 Tell their doctor if feeling ill0.131.14(1.02, 1.27) *
Attitude to the government
 Movement tracking0.131.14(1.01, 1.27) *
 Release of patients’ information-0.140.87(0.79, 0.96) **
 Financial aid0.141.15(1.00, 1.31) **
 Trustworthy of government’s information0.301.35(1.21, 1.52) ****
 Negative impact of misinformation0.131.14(1.00, 1.29) *
COVID-related risk factors
 Level three alert1.032.80(2.16, 3.65) ****
 Test negative0.692.00(1.29, 3.17) **
Reasons influencing the motivation for vaccination
 Physical impact-0.280.75(0.58, 0.97) ***
 Vaccination process-0.340.71(0.56, 0.90) **
 Other-0.870.42(0.29, 0.61) ****

*: p <.05;

**: p <.01;

***: p <.001;

****: p <.0001.

*: p <.05; **: p <.01; ***: p <.001; ****: p <.0001. Among the psychological perspectives, people who scored one more score in the personality trait of openness would increase their vaccination willingness with a multiple of 1.07. In other words, the more inventive/curious the participants were towards new experiences, the more likely they were to want to get vaccinated. Besides, in the QoL section, those who scored one more score in the physical health domain would like to get vaccinated with a multiple of 1.08. Nevertheless, higher social relationships lead to a higher chance of vaccination hesitancy (motivation increased by a multiple of 0.94 per unit). In the participants’ public health knowledge and personal health behavior section, those who usually go to crowded places (with a multiple of 1.28 per unit) or who were used to telling their doctor when feeling ill (with a multiple of 1.14 per unit) had more incentive to vaccinate. Considering attitudes towards the government, people who strongly approved or supported that the government could track how people move around in order to control the outbreak (with a multiple of 1.14 per unit) and that the government should provide financial aid due to the economic crisis (with a multiple of 1.15 per unit), tended to have a higher vaccination willingness. In contrast, people who strongly disagreed with, the government releasing patients’ information (with a multiple of 0.87 per unit) were more willing to vaccinate. Moreover, those who thought the information provided by their government about the development of the epidemic was trustworthy (with a multiple of 1.35 per unit) or if they were worried about the negative impact of misinformation related to epidemic prevention on society (with a multiple of 1.14 per unit), tended to have a higher preference to vaccinate.

RQ3: How do COVID-related risk factors and potential threats affect one’s vaccine intention?

When the Taiwanese government issued a COVID-19 level three alert, the willingness of participants to vaccinate increased by a multiple of 2.8. The previous daily new confirmed cases was statistically insignificant, and we found that its effect was offset by the COVID-19 level three alert. Those who tested negative for the COVID-19 virus were more willing to vaccinate with a multiple of 2. It is important to note that all the participants who had a COVID-19 test in the survey had negative results, therefore, the participants could have had a higher level of risk, pressuring them to take a COVID-19 test and thus had higher vaccination preference. Lastly, among the reasons influencing the vaccine motivation, people who cared about the vaccination process (with a multiple of 0.71) or other reasons (with a multiple of 0.42) were unwilling to vaccinate. Considering the risk of taking the vaccination, participants worried about the vaccine’s physical impact were more willing to take the vaccination than those who did not (with a multiple of 0.75).

Discussion

The value of this study is highlighted by its time period, having been performed in a time window containing the time ahead, the start, and the peak of the most severe COVID-19 outbreak in Taiwan. For 253 days in 2020, Taiwan reported zero locally-transmitted cases of COVID-19. As we performed the survey from March to May 2021, people had experienced the substantial impacts of COVID-19 on their day-to-day life, changing their attitudes toward vaccinating. We examined various potential factors that could affect one’s vaccination intentions and aimed to investigate the most important factors among various aspects that could lead to one’s vaccinating decision. We clearly demonstrated that the participants’ attitudes towards vaccinating had changed significantly as their risks of being infected increased. Moreover, there were not many available vaccines to choose from in Taiwan, and people did not have many discussions about multiple choices of vaccines. Therefore, the effect of vaccines’ branding could be limited. First of all, among all the sociodemographic factors we included, we found that only gender and age could be included in our final statistical model. Specifically, from our participants, men and people over 30 years old have higher vaccination intentions, which concurs with many previous studies in different countries [4, 5, 9, 12, 18, 27, 29, 31, 32] and in Taiwan by [35]. Furthermore, psychological indicators also affected vaccination intentions. Our study demonstrated that Individuals with higher openness are more likely to get vaccinated. As open individuals pursue new and unconventional ideas and experiences and tend to be flexible, inventive, and creative [56], they would be open to vaccination and thus have higher vaccination intentions. When facing a pandemic, the results of our study showed that those who scored high for physical health tended to vaccinate. A possible explanation for this trend is that the habit for individuals to maintain good physical health triggers them to vaccinate. Additionally, there was a negative indication of the social relationships dimension. We suggest that this dimension was a suppressor in our regression model and was not correlated to the willingness to be vaccinated (the correlation coefficient was only -0.0016 to the dependent variable) but was highly correlated with other variables and improved the performance of the model. People who have better public health knowledge and personal health behavior tend to have a higher vaccination willingness [3, 29]. In the participants’ public health knowledge and personal health behavior domain, we found that individuals who usually go to crowded places or who were accustomed to notifying their doctor when feeling ill had higher vaccination willingness. The effects of these factors were as expected. As many studies in health belief models suggested [29, 57], individuals’ risk-taking propensity should be aligned with their attitudes toward different health-related behaviors. Intrinsic beliefs of the benefits of vaccines could motivate people to vaccinate. Regarding the participants’ attitudes toward the government, individuals who trusted information from the government and those who agreed with the government’s policy of movement tracking and providing financial aid were more willing to vaccinate. In similarity to previous studies [24, 42, 58], trust in government also plays an important role in the vaccination decision-making process. Further, the more value people placed on individual privacy, the higher their willingness to vaccinate. This effect was not investigated by previous studies. Moreover, according to [3, 59, 60], misinformation is more strongly associated with declines in vaccination intent, and susceptibility to misinformation and vaccine hesitancy lead to a reduced likelihood to comply with health guidance measures. In our study, those who were worried about the negative impact of misinformation also tended to have a higher willingness to vaccinate. Rather than basing the intention to vaccinate on the threat of infection and its consequences, vaccine intentions are rather based on perceived individual risks such as severity and susceptibility [3, 11, 57]. As mentioned, most of the confirmed cases of the outbreak occurred in Taipei, however, there is no significant difference from many variables for people living in Taipei to have a higher intent to vaccinate. Since most locations in Taiwan can be reached within a few hours, it is reasonable for people from different locations share the same level of perceived risks and vaccination intent. Nevertheless, those who had tested for the COVID-19 virus tended to have higher vaccination intentions. There was no widespread COVID-19 screening before or during the outbreak, however, certain places and professions required recent proof of a COVID-19 negative test result. Therefore those who had had COVID-19 tests, all of which were negative, could have had a higher need to vaccinate, when compared to the general public. Furthermore, the timing and the development of viruses and diseases influenced perceived risks too. In our model, both the timing of the COVID-19 level three alert and the previous daily new confirmed cases had strong impacts on one’s vaccination intentions. Our results showed that participants’ vaccination intent was highly sensitive to time and the risk of infection people perceive. Accordingly, the vaccination acceptance rate had been growing from 53% in October 2020 [43] to a substantially higher amount, 87% of people vaccinated against COVID-19 in June 2022 [49]. Lastly, various studies showed that concern about side effects of vaccines are the most common cause for hesitancy [6, 17, 23, 27, 30, 35, 37, 41, 61]. In our study, while considering the risks of a vaccination, people’s motivation for vaccinating was strengthened by considering the physical impact of the vaccine. This physical impact in our model was neutral, and it was an aspect participants considered. In contrast, the risk of the vaccination process or other reasons lowered their motivation. This study had its limitations. First, we attempted to use different mediums to recruit participants, but the online survey was biased toward internet users. Additionally, participant panels can be subject to bias and may not be representative of the general population. Our participants tended to have greater internet access and higher socioeconomic status [62]. Secondly, for each participant, this survey only reflected a snapshot taken at a certain point in time, not accommodating for the potential change in a participants’ willingness to vaccinate over time [63]. Finally, the study was performed in Taiwan only, limiting our accountability for unique aspects from other countries.

Conclusions

Using a 10 week nationwide online survey performed during a time period containing the time ahead, the start, and the peak of a COVID-19 outbreak, we investigated many aspects that could affect participants’ vaccination intentions. The domains we explored were multidimensional, including individuals’ demographic factors, personality traits, QoL, public health knowledge, personal health behavior, attitude toward the government, reasons to consider being vaccinated and COVID-19 vaccination related risk factors. Our study confirmed many findings from previous studies which suggest that being male, older people, improved knowledge and personal health behavior, trust in government, and concern about misinformation tended to increase vaccination intent. There were some distinctive findings in our study as well. We found that people with an open personality and better QoL in the physical health domain were inclined to vaccinate. Perceived risks played a crucial role in the vaccine decision-making process too. When the pandemic became more severe, participants’ vaccination intent increased significantly. The findings of the present study could shed light on individuals’ vaccination attitude and may provide governments with an empirical and dynamic base to design tailored strategies to reach higher vaccination rates. 30 May 2022
PONE-D-22-05839
Determinants of personal vaccination hesitancy before and after the COVID-19 outbreak in Taiwan
PLOS ONE Dear Dr. Authors, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 14 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Srikanth Umakanthan Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”). For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: This research was funded by the Academia Sinica, Taiwan (AS-IRB-HS07-109104 and 284 AS-IRB-HS07-109090) for the first author. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: This research was funded by the Academia Sinica, Taiwan https://www.sinica.edu.tw/en (AS-IRB-HS07-109104 and AS-IRB-HS07-109090) for the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 6. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Dear Authors, Thanks for submitting your manuscript to PLOS ONE. Your manuscript was reviewed by two esteemed reviewers and the reports are available. Minor revisions required as provided by the two esteemed reviewers. Address these issues point-wise and resubmit the revised manuscript highlighting the changes with both track changes and color highlighted text in the manuscript. Regards, Srikanth Umakanthan [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thanks a lot for the opportunity to review this interesting and timely manuscript. In this study, Hsuan-Wei Lee et al, investigated COVID-19 vaccine hesitancy in Taiwan and its associated factors. This is a timely study considering the recent record number of COVID-19 cases in Taiwan. The study design is robust, and the authors used a cross-sectional national survey before and during the first noticeable increase in the number of COVID-19 cases in Taiwan between March 2021 and May 2021 to assess the attitude of the general population to COVID-19 vaccination with a large sample size. Overall, the manuscript is well-written, and the findings represent a significant contribution to the field of COVID-19 vaccine hesitancy. The manuscript is well organized and is comprehensively described and it was written in correct and readable language. The research design was proper, the methods were adequately described, the results were presented clearly with sufficient Tables, and the conclusions were supported by the results. Importantly, the potential limitations were presented clearly by the authors. Minor comments: 1. The authors can benefit from revising the title which can be a bit vague for the readers from countries where the first wave (outbreak) of COVID-19 occurred in the first half of 2020 rather than 2021. 2. In the Introduction section, lines 9-18, the authors can benefit from two additional reference on COVID-19 vaccine acceptance rates worldwide and in Taiwan: A. https://doi.org/10.2147/JMDH.S347669 B. https://doi.org/10.3390/ijerph18115579 3. In the Introduction section, lines 33-37, the authors can benefit from adding more information regarding the number of cases and mortalities that occurred during the first wave (if it can be called so) of COVID-19 in Taiwan in May 2021 4. In the Introduction section, line 39: please add a reference to support this statement 5. In Figure 1, please add the reference from which this relevant data was retrieved. 6. In Table 1, please add a footnote to spell out the abbreviations (e.g. WHO). The same applies for Table 2 (USD) 7. In the Discussion section, the authors can benefit from adding a paragraph to compare the acceptance rate to COVID-19 vaccination in Taiwan to that in neighbouring countries which were much higher (e.g. China 82%, South Korea 77%) using the aforementioned reference: https://doi.org/10.2147/JMDH.S347669 Reviewer #2: Comments to the Author My comments are as follows: 1. Abstract- Well structured and summarizes the overall purpose of the study and the research problem(s) investigated. The basic design of the study; major findings and trends found as a result of the study is also showcased. 2. Materials and methods- The authors have included a proper survey questionnaire along with the assessment scale to analyze their objectives. 3. Statistics: The involvement of regression methods (logistic and linear models) provides clearance of bias that may have generated by the different variables. The confounding/impending factors are well neutralized by the statistical methods. 4. Discussion: The discussion requires more additional statements with regards to the existing literature search. Include the following references and citations reflecting the COVID-19 updates to strengthen the manuscript: - Origin and transmission (use reference and cite:  doi:10.1136/postgradmedj-2020-138234) - To mention in brief about vaccines (use reference and cite: “doi: 10.1136/postgradmedj-2021-141365. AND  doi:10.1136/postgradmedj-2021-140654”) - Definition of vaccine resistance and hesitance (use reference and cite: doi:10.3390/vaccines9101064). - Compare the global vaccine status and relate it with the current vaccine status (refer and cite:  doi:10.3934/publichealth.2021053) 5. Conclusion: The authors have shown the importance of variables that can influence the adherence of preventive measures and willingness to vaccinate against COVID-19. The main bulletin messages showcases the summary of the manuscript very well. I advocate this article for revision pending inclusion of the points as recommended by me. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
6 Jun 2022 Authors’ response We deeply thank the referees for their insightful and helpful comments on our paper. We believe they have helped us to improve the paper. We have made according revisions to the manuscript. In order to meet the requirement of the reviewer, a significant change to the paper is that we rename the title to “Determinants of personal vaccination hesitancy before and after the mid-2021 COVID-19 outbreak in Taiwan.” We believe this title is more consistent with the content of the manuscript too. Moreover, in order to meet the requirements from the journal, we made some cosmetic changes of ethic statements in the new manuscript too. Below we respond to individual comments from the referees. We use black text for the reviewers’ comments and our reply in blue. In the manuscript, we use blue color for the text we added. Reviewer #1: Thanks a lot for the opportunity to review this interesting and timely manuscript. In this study, Hsuan-Wei Lee et al, investigated COVID-19 vaccine hesitancy in Taiwan and its associated factors. This is a timely study considering the recent record number of COVID-19 cases in Taiwan. The study design is robust, and the authors used a cross-sectional national survey before and during the first noticeable increase in the number of COVID-19 cases in Taiwan between March 2021 and May 2021 to assess the attitude of the general population to COVID-19 vaccination with a large sample size. Overall, the manuscript is well-written, and the findings represent a significant contribution to the field of COVID-19 vaccine hesitancy. The manuscript is well organized and is comprehensively described and it was written in correct and readable language. The research design was proper, the methods were adequately described, the results were presented clearly with sufficient Tables, and the conclusions were supported by the results. Importantly, the potential limitations were presented clearly by the authors. Minor comments: 1. The authors can benefit from revising the title which can be a bit vague for the readers from countries where the first wave (outbreak) of COVID-19 occurred in the first half of 2020 rather than 2021. We agree with the reviewer that the old title is a little bit unclear. Following the reviewer’s suggestion, we change the title of this article as “Determinants of personal vaccination hesitancy before and after the mid-2021 COVID-19 outbreak in Taiwan.” We deeply appreciate the reviewer’s valuable suggestion. 2. In the Introduction section, lines 9-18, the authors can benefit from two additional reference on COVID-19 vaccine acceptance rates worldwide and in Taiwan: A. https://doi.org/10.2147/JMDH.S347669 B. https://doi.org/10.3390/ijerph18115579 We thank the reviewer’s suggestion. The two additional references are indeed relevant to this research and they are both added in the new manuscript (line 14). We also added two supplementary references to illustrate the initial success of controlling the COVID-19 epidemic (line 27). 3. In the Introduction section, lines 33-37, the authors can benefit from adding more information regarding the number of cases and mortalities that occurred during the first wave (if it can be called so) of COVID-19 in Taiwan in May 2021. We appreciate the reviewer’s suggestion. The information regarding the number of cases and mortalities are now provided (line 36-40). 4. In the Introduction section, line 39: please add a reference to support this statement. We thank the reviewer’s suggestion and add a reference to support the statement in the new manuscript (line 45). 5. In Figure 1, please add the reference from which this relevant data was retrieved. We thank the reviewer’s suggestion. The dataset we referred to is cited in the new manuscript (line 64). 6. In Table 1, please add a footnote to spell out the abbreviations (e.g. WHO). The same applies for Table 2 (USD) We appreciate the reviewer’s reminder and spell out the two abbreviations we used in the new manuscript. 7. In the Discussion section, the authors can benefit from adding a paragraph to compare the acceptance rate to COVID-19 vaccination in Taiwan to that in neighbouring countries which were much higher (e.g. China 82%, South Korea 77%) using the aforementioned reference: https://doi.org/10.2147/JMDH.S347669 We thank the reviewer’s suggestion and think it is indeed important for us to make a comparison of vaccination acceptance rates to the nearby countries. However, the reason Taiwan has a relatively low acceptance rate to COVID-19 vaccination in this study is mainly because that the survey was done in the period that there was no local COVID-19 cases spreading in Taiwan for several months. When the pandemic is eminent, people’s vaccination acceptance rates would grow much higher, and this is also consistent to our main finding in the manuscript. Our results showed that participants’ vaccination intent was highly sensitive to time and the risk of infection people perceive. To put elaborate on this more clearly, we added several sentences in the new manuscript accordingly (line 28-30 and 259-262). Reviewer #2: Comments to the Author My comments are as follows: 1. Abstract- Well structured and summarizes the overall purpose of the study and the research problem(s) investigated. The basic design of the study; major findings and trends found as a result of the study is also showcased. 2. Materials and methods- The authors have included a proper survey questionnaire along with the assessment scale to analyze their objectives. 3. Statistics: The involvement of regression methods (logistic and linear models) provides clearance of bias that may have generated by the different variables. The confounding/impending factors are well neutralized by the statistical methods. 4. Discussion: The discussion requires more additional statements with regards to the existing literature search. Include the following references and citations reflecting the COVID-19 updates to strengthen the manuscript: - Origin and transmission (use reference and cite: doi:10.1136/postgradmedj-2020-138234) - To mention in brief about vaccines (use reference and cite: “doi: 10.1136/postgradmedj-2021-141365. AND doi:10.1136/postgradmedj-2021-140654”) - Definition of vaccine resistance and hesitance (use reference and cite: doi:10.3390/vaccines9101064). - Compare the global vaccine status and relate it with the current vaccine status (refer and cite: doi:10.3934/publichealth.2021053) 5. Conclusion: The authors have shown the importance of variables that can influence the adherence of preventive measures and willingness to vaccinate against COVID-19. The main bulletin messages showcases the summary of the manuscript very well. I advocate this article for revision pending inclusion of the points as recommended by me. We thank the reviewer for the nice comments. Moreover, we appreciate the reviewer’s suggestion and we think these references could make our research more comprehensive. The above references are indeed related to this research and we add these references in the new manuscript (in line 2, line 10, line 264, line 11, and line 13, respectively). Submitted filename: response.docx Click here for additional data file. 9 Jun 2022 Determinants of personal vaccination hesitancy before and after the mid-2021 COVID-19 outbreak in Taiwan PONE-D-22-05839R1 Dear Dr. Lee, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Srikanth Umakanthan Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thanks for addressing all the previous comments properly and thoroughly. The manuscript is well written and provides timely and important results. Reviewer #2: The authors have addressed all of my comments and the manuscript now appears to be of sound nature and of acceptable standards in accordance with the journal requirements. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** 13 Jun 2022 PONE-D-22-05839R1 Determinants of personal vaccination hesitancy before and after the mid-2021 COVID-19 outbreak in Taiwan Dear Dr. Lee: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Srikanth Umakanthan Academic Editor PLOS ONE
  55 in total

1.  The Persistence of Vaccine Hesitancy: COVID-19 Vaccination Intention in New Zealand.

Authors:  Jagadish Thaker
Journal:  J Health Commun       Date:  2021-03-15

2.  Mandatory Vaccination in Europe.

Authors:  Olivia M Vaz; Mallory K Ellingson; Paul Weiss; Samuel M Jenness; Azucena Bardají; Robert A Bednarczyk; Saad B Omer
Journal:  Pediatrics       Date:  2020-01-13       Impact factor: 7.124

3.  Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey.

Authors:  Mohammed Al-Mohaithef; Bijaya Kumar Padhi
Journal:  J Multidiscip Healthc       Date:  2020-11-20

4.  Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults.

Authors:  Kimberly A Fisher; Sarah J Bloomstone; Jeremy Walder; Sybil Crawford; Hassan Fouayzi; Kathleen M Mazor
Journal:  Ann Intern Med       Date:  2020-09-04       Impact factor: 25.391

5.  Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom.

Authors:  Jamie Murphy; Frédérique Vallières; Richard P Bentall; Mark Shevlin; Orla McBride; Todd K Hartman; Ryan McKay; Kate Bennett; Liam Mason; Jilly Gibson-Miller; Liat Levita; Anton P Martinez; Thomas V A Stocks; Thanos Karatzias; Philip Hyland
Journal:  Nat Commun       Date:  2021-01-04       Impact factor: 14.919

6.  Comparison of Estimated Effectiveness of Case-Based and Population-Based Interventions on COVID-19 Containment in Taiwan.

Authors:  Ta-Chou Ng; Hao-Yuan Cheng; Hsiao-Han Chang; Cheng-Chieh Liu; Chih-Chi Yang; Shu-Wan Jian; Ding-Ping Liu; Ted Cohen; Hsien-Ho Lin
Journal:  JAMA Intern Med       Date:  2021-07-01       Impact factor: 21.873

7.  Community Outbreak Moderates the Association Between COVID-19-Related Behaviors and COVID-19 Fear Among Older People: A One-Year Longitudinal Study in Taiwan.

Authors:  Yi-Jie Kuo; Yu-Pin Chen; Hsiao-Wen Wang; Chieh-Hsiu Liu; Carol Strong; Mohsen Saffari; Nai-Ying Ko; Chung-Ying Lin; Mark D Griffiths
Journal:  Front Med (Lausanne)       Date:  2021-12-17

8.  Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia.

Authors:  Mallory Trent; Holly Seale; Abrar Ahmad Chughtai; Daniel Salmon; C Raina MacIntyre
Journal:  Vaccine       Date:  2021-06-23       Impact factor: 3.641

9.  Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study.

Authors:  Alexandre de Figueiredo; Clarissa Simas; Emilie Karafillakis; Pauline Paterson; Heidi J Larson
Journal:  Lancet       Date:  2020-09-10       Impact factor: 202.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.